FR167653 reduces obliterative airway disease in rats

Journal of Heart and Lung Transplantation

Volumn 23, Issue 8, 2004, Pages 985-992

  Farivar, Alexander S ^a   Mackinnon Patterson, Brendan ^a   Woolley, Steven ^a   Namkung, Jane ^a   Shimamoto, Akira ^a   Verrier, Edward D ^a   Mulligan, Michael S ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [7 (4 FLUOROPHENYL) 1,2,3,4 TETRAHYDRO 8 (4 PYRIDYL)PYRAZOLO[5,1 C][1,2,4]TRIAZIN 2 YL] 2 PHENYLETHANEDIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AUTOMATION; BRONCHIOLITIS; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; EXPERIMENTAL RAT; GEL MOBILITY SHIFT ASSAY; IMMUNOHISTOCHEMISTRY; LUNG TRANSPLANTATION; MALE; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; RAT STRAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; TRACHEA; TRACHEA OBSTRUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BRONCHIOLITIS OBLITERANS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1; LUNG TRANSPLANTATION; MALE; MODELS, ANIMAL; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; POSTOPERATIVE COMPLICATIONS; PYRAZOLES; PYRIDINES; RATS; RATS, INBRED LEW; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TRANSCRIPTION, GENETIC; TRANSPLANTATION, HOMOLOGOUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 4243135859     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2004.04.008     Document Type: Conference Paper

References (23)

1. A. Boehler, M. Estenne Obliterative bronchiolitis after lung transplantation Curr Opin Pulm Med 6 2000 133 139
2. C. Smith, A. Jaramillo, K. Lu, T. Higuchi, Z. Kaleem, T. Mohanakumar Prevention of obliterative airway disease in HLA-A2-transgenic tracheal allografts by neutralization of tumor necrosis factor Transplant 72 2001 1512 1518
3. M.H. Cobb, E.J. Goldsmith How MAP kinases are regulated J Biol Chem 270 1995 14843 14846
4. F. Chen, M. Ding, Y. Lu Participation of MAP kinase p38 and IkappaB kinase in chromium (VI)-induced NF-kappaB and AP-1 activation J Environ Pathol Toxicol Oncol 19 2000 231 238
5. D. Wang, A. Richmond Nuclear factor-kappa B activation by the CXC chemokine melanoma growth-stimulatory activity/growth-regulated protein involves the MEKK1/p38 mitogen-activated protein kinase pathway J Biol Chem 276 2001 3650 3659
6. Y. Kawashima, I. Takeyoshi, Y. Otani FR167653 attenuates ischemia and reperfusion injury of the rat lung with suppressing p38 mitogen activated protein kinase J Heart Lung Transplant 20 2001 568 574
7. S. Takahashi, Y. Keto, T. Fujita, T. Uchiyama, A. Yamamoto FR167653, a p38 MAP kinase inhibitor, prevents H pylori induced gastritis in Mongolian gerbils J Pharm Exp Ther 296 2001 48 56
8. S. Hato, A. Urakami, T. Yamano Attenuation of liver and lung injury after hepatic ischemia and reperfusion by a cytokine-suppressive agent, FR167653 Eur Surg Res 33 2001 202 209
9. K.L. Chan, W.H. Guo, K.W. Chan, P.K. Tam FR167653 ameliorates intestinal allograft ischemic injury Transplant Proc 32 2000 1643 1644
10. T. Nishikori, K. Irie, T. Suganuma, M. Ozaki, T. Yoshioka Anti-inflammatory potency of FR167653 in mouse models of acute inflammation Eur J Pharm 451 2002 327 333
11. D.J. Hele, M.H. Yacoub, M.G. Belvisi The heterotopic tracheal allograft as an animal model of obliterative bronchiolitis Respir Res 2 2001 169 183
12. N. Yamamoto, F. Sakai, H. Yamazaki Effect of FR167653, a cytokine suppressive agent, on endotoxin induced disseminated intravascular coagulation Eur J Pharm 314 1996 137 142
13. Blandino II, M. Otaka, M. Jin FR167653, a potent suppressant of interleukin-1 and tumor necrosis factor-alpha production, ameliorates colonic lesions in experimentally induced acute colitis J Gastroenterol Hepatol 16 2001 1105 1111
14. M. Kobayashi, I. Takeyoshi, D. Yoshinari, K. Matsumoto, Y. Morishita p38 mitogen-activated protein kinase inhibition attenuates ischemia-reperfusion injury of the rat liver Surgery 131 2002 344 349
15. H. Kitada, A. Sugitani, H. Yamamoto Attenuation of renal ischemia-reperfusion injury by FR167653 in dogs Surgery 131 2002 654 662
16. S. Hoshida, N. Yamashita, K. Otsu, M. Hori FR167653, a cytokine-suppressive agent, reduces myocardial ischemia-reperfusion injury in rats Cytokines Cell Mol Ther 6 2000 165 170
17. M. Nishikawa, A. Myoui, T. Tomita, K. Takahi, A. Nampei, H. Yoshikawa Prevention of the onset and progression of collagen-induced arthritis in rats by the potent p38 mitogen-activated protein kinase inhibitor FR167653 Arthritis Rheum 48 2003 2670 2681
18. N. Kobayashi, T. Kataoka, A. Ono, Y. Tsukimi, S. Okabe Role of p38 mitogen-activated protein kinase in the healing of gastric ulcers in rats J Physiol Pharmacol 52 2001 195 210
19. H. Ishikawa, I. Takeyoshi, M. Aiba The effective dose of FR167653 in pulmonary ischemia-reperfusion injury Int J Surg Invest 2 2000 243 252
20. D. Yoshinari, I. Takeyoshi, Y. Koibuchi Effects of a dual inhibitor of tumor necrosis factor alpha and interleukin 1 on LPS induced lung injury in rats involvement of the p38 MAP kinase pathway Crit Care Med 29 2001 628 634
21. H. Matsuoka, T. Arai, M. Mori A p38 MAP kinase inhibitor, FR167653, ameliorates bleomycin induced pulmonary fibrosis Am J Physiol Lung Cell Mol Physiol 283 2002 103 112
22. B.V. Naidu, A.S. Farivar, B. Krishnadasan Broad-spectrum chemokine inhibition ameliorates experimental obliterative bronchiolitis Ann Thorac Surg 75 2003 1118 1122
23. J.M. Tikkanen, K. Lemstrom, P. Koskinen Blockade of CD 28/B72 costimulation inhibits experimental obliterative bronchiolitis in rat tracheal allografts Am J Respir Crit Care Med 165 2002 724 729